Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
Search for other papers by Amir Bashkin in
Google Scholar
PubMed
Search for other papers by Eliran Yaakobi in
Google Scholar
PubMed
Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
Search for other papers by Marina Nodelman in
Google Scholar
PubMed
Department of Otolaryngology Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel
Search for other papers by Ohad Ronen in
Google Scholar
PubMed
diagnoses: overt hypothyroidism, subclinical hypothyroidism, overt thyrotoxicosis, subclinical thyrotoxicosis and non-thyroidal illness syndrome (NTIS) and/or effect of drugs. It is impossible to differentiate between the latter two based on thyroid function
Search for other papers by Jiashu Li in
Google Scholar
PubMed
Search for other papers by Aihua Liu in
Google Scholar
PubMed
Department of Endocrinology and Metabolism, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China
Search for other papers by Haixia Liu in
Google Scholar
PubMed
Search for other papers by Chenyan Li in
Google Scholar
PubMed
Search for other papers by Weiwei Wang in
Google Scholar
PubMed
Search for other papers by Cheng Han in
Google Scholar
PubMed
Search for other papers by Xinyi Wang in
Google Scholar
PubMed
Search for other papers by Yuanyuan Zhang in
Google Scholar
PubMed
Search for other papers by Weiping Teng in
Google Scholar
PubMed
Search for other papers by Zhongyan Shan in
Google Scholar
PubMed
Introduction Thyroid dysfunction is a common endocrine disorder among reproductively aged women ( 1 ), with a morbidity of 2–3%. Subclinical hypothyroidism (SCH) is the most common condition of thyroid disorders during pregnancy ( 2 ) and is
Search for other papers by Xin He in
Google Scholar
PubMed
Search for other papers by Qin Yan in
Google Scholar
PubMed
Search for other papers by Chazhen Liu in
Google Scholar
PubMed
Search for other papers by Zhengyuan Wang in
Google Scholar
PubMed
Search for other papers by Ping Liao in
Google Scholar
PubMed
Search for other papers by Tong Liu in
Google Scholar
PubMed
Search for other papers by Zehuan Shi in
Google Scholar
PubMed
Search for other papers by Qi Song in
Google Scholar
PubMed
Search for other papers by Xueying Cui in
Google Scholar
PubMed
Search for other papers by Wenjing Wang in
Google Scholar
PubMed
Search for other papers by Jiajie Zang in
Google Scholar
PubMed
-positive women without thyroid disease history and goiters. We defined overt hypothyroidism as TSH concentration over the 97.5th percentile with an FT4 concentration below the 2.5th percentile. Subclinical hypothyroidism was defined as TSH concentration above
Search for other papers by Ning Yuan in
Google Scholar
PubMed
Search for other papers by Jianbin Sun in
Google Scholar
PubMed
Search for other papers by Xin Zhao in
Google Scholar
PubMed
Search for other papers by Jing Du in
Google Scholar
PubMed
Search for other papers by Min Nan in
Google Scholar
PubMed
Search for other papers by Qiaoling Zhang in
Google Scholar
PubMed
Search for other papers by Xiaomei Zhang in
Google Scholar
PubMed
Introduction Maternal subclinical hypothyroidism (SCH), which is defined as an increased thyroid-stimulating hormone (TSH) concentration beyond the upper limit of the pregnancy-specific reference range and a normal free-thyroxine (FT4
Search for other papers by Madalena von Hafe in
Google Scholar
PubMed
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar São João, Porto, Portugal
Search for other papers by João Sergio Neves in
Google Scholar
PubMed
Search for other papers by Catarina Vale in
Google Scholar
PubMed
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar São João, Porto, Portugal
Search for other papers by Marta Borges-Canha in
Google Scholar
PubMed
Search for other papers by Adelino Leite-Moreira in
Google Scholar
PubMed
with pulmonary hypertension – albeit less frequently – and atrioventricular valve regurgitation, mainly of the tricuspid valve ( 49 ). Heart failure is the main cause of increased cardiovascular mortality in both overt hyperthyroidism and subclinical
Search for other papers by Bogumila Urgatz in
Google Scholar
PubMed
Search for other papers by Kris G Poppe in
Google Scholar
PubMed
reproduction also proposes 4.0 μIU/mL as an upper limit to the TSH reference range, unless a locally derived reference range has a higher value ( 10 ). As in other settings, the diagnosis of subclinical hypothyroidism (SCH) is made when TSH is above the upper
Search for other papers by Xi Cao in
Google Scholar
PubMed
Search for other papers by Ming Lu in
Google Scholar
PubMed
Search for other papers by Rong-Rong Xie in
Google Scholar
PubMed
Search for other papers by Li-Ni Song in
Google Scholar
PubMed
Search for other papers by Wei-Li Yang in
Google Scholar
PubMed
Search for other papers by Zhong Xin in
Google Scholar
PubMed
Search for other papers by Guang-Ran Yang in
Google Scholar
PubMed
Search for other papers by Jin-Kui Yang in
Google Scholar
PubMed
% of patients with type 1 diabetes (T1DM) would suffer from DME after 10 years of follow-up ( 5 ). Thyroid dysfunctions, including clinical and subclinical thyroid dysfunction, are common diseases with a prevalence of up to 10% in the general
Search for other papers by Clara Lundetoft Clausen in
Google Scholar
PubMed
Search for other papers by Åse Krogh Rasmussen in
Google Scholar
PubMed
Search for other papers by Trine Holm Johannsen in
Google Scholar
PubMed
Search for other papers by Linda Maria Hilsted in
Google Scholar
PubMed
Search for other papers by Niels Erik Skakkebæk in
Google Scholar
PubMed
Search for other papers by Pal Bela Szecsi in
Google Scholar
PubMed
Search for other papers by Lise Pedersen in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Thomas Benfield in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Anders Juul in
Google Scholar
PubMed
: overt thyrotoxicosis (TSH < 0.4 mIU/L and free T 4 > 22.0 pmol/L); subclinical thyrotoxicosis (TSH < 0.4 mIU/L and 12.0 ≤ free T 4 ≤ 22.0 pmol/L); overt hypothyroidism (TSH > 4.8 mIU/L and free T 4 < 12.0 pmol/L); subclinical hypothyroidism (TSH > 4
Search for other papers by Xiaoya Zheng in
Google Scholar
PubMed
Search for other papers by Heng Xiao in
Google Scholar
PubMed
Search for other papers by Jian Long in
Google Scholar
PubMed
Search for other papers by Qiang Wei in
Google Scholar
PubMed
Search for other papers by Liping Liu in
Google Scholar
PubMed
Search for other papers by Liping Zan in
Google Scholar
PubMed
Search for other papers by Wei Ren in
Google Scholar
PubMed
(ACR TI-RADS) guidelines (2017) ( 12 ). Definition of thyroid dysfunction The diagnosis of thyrotoxicosis was defined as a TSH value <0.56 µIU/mL with (overt thyrotoxicosis) or without (subclinical thyrotoxicosis) elevated FT3 or FT4 levels. The
Search for other papers by Satoshi Higuchi in
Google Scholar
PubMed
Search for other papers by Hideki Ota in
Google Scholar
PubMed
Search for other papers by Takuya Ueda in
Google Scholar
PubMed
Search for other papers by Yuta Tezuka in
Google Scholar
PubMed
Search for other papers by Kei Omata in
Google Scholar
PubMed
Search for other papers by Yoshikiyo Ono in
Google Scholar
PubMed
Search for other papers by Ryo Morimoto in
Google Scholar
PubMed
Search for other papers by Masataka Kudo in
Google Scholar
PubMed
Division of Clinical Hypertension, Endocrinology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
Search for other papers by Fumitoshi Satoh in
Google Scholar
PubMed
Search for other papers by Kei Takase in
Google Scholar
PubMed
CPTs. We hypothesized that CMR may be able to identify the regional variance of the catecholamine-induced myocardial damage in patients with CPTs without contrast medium. We aimed to evaluate whether CMR could detect subclinical catecholamine